BYOT Byotrol Plc

TIDMBYOT

RNS Number : 6202Y

Byotrol PLC

07 December 2017

Byotrol plc

("Byotrol" or the "Company")

Notice of Results

The Company announces that it will be releasing its interim results for the six months ended 30 September 2017 on Thursday 14 December 2017.

Contacts:

Byotrol plc 01925 742 000

David Traynor - Chief Executive

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne - Corporate Finance

Richard Chambers - Broking

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives

For more information, please go to www.byotrol.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORUGGUCPUPMGMQ

(END) Dow Jones Newswires

December 07, 2017 02:01 ET (07:01 GMT)

Byotrol (LSE:BYOT)
Historical Stock Chart
From Mar 2024 to Apr 2024

Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2023 to Apr 2024